标题
NAFLD: An Emerging Causal Factor for Cardiovascular Disease
作者
关键词
-
出版物
PHYSIOLOGY
Volume 38, Issue 6, Pages 255-265
出版商
American Physiological Society
发表日期
2023-07-11
DOI
10.1152/physiol.00013.2023
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH
- (2023) Silvia Marchianò et al. Scientific Reports
- The role of hepatokines in NAFLD
- (2023) Norbert Stefan et al. Cell Metabolism
- The postprandial actions of GLP-1 receptor agonists: The missing link for cardiovascular and kidney protection in type 2 diabetes
- (2023) Merlin C. Thomas et al. Cell Metabolism
- Inflammation in obesity, diabetes, and related disorders
- (2022) Theresa V. Rohm et al. IMMUNITY
- Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences
- (2022) Armando Tripodi et al. Biomedicines
- Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications
- (2022) Doris Ogresta et al. Journal of Clinical and Translational Hepatology
- Synthesis of heterocyclic ring-fused analogs of HMG499 as novel degraders of HMG-CoA reductase that lower cholesterol
- (2022) Xing-Zi Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Relationship between NAFLD and coronary artery disease: A Mendelian randomization study
- (2022) Zhewen Ren et al. HEPATOLOGY
- Impaired fibrinolysis without hypercoagulability characterises patients with non-alcoholic fatty liver disease
- (2022) Peter Lykke Eriksen et al. THROMBOSIS RESEARCH
- Renin–Angiotensin System in Liver Metabolism: Gender Differences and Role of Incretins
- (2022) Zainab Mastoor et al. Metabolites
- Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease
- (2022) Ke-Qiong Deng et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Associations of genetically predicted IL-6 signaling with cardiovascular disease risk across population subgroups
- (2022) Marios K. Georgakis et al. BMC Medicine
- The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study
- (2022) Jiarong Xie et al. HEPATOLOGY
- The contribution of the gut-liver axis to the immune signaling pathway of NAFLD
- (2022) Jiayi Liu et al. Frontiers in Immunology
- Physiological And Pathological Roles Of Protein Kinase A In The Heart
- (2021) Yuening Liu et al. CARDIOVASCULAR RESEARCH
- Metabolic stress drives sympathetic neuropathy within the liver
- (2021) Kaili Liu et al. Cell Metabolism
- Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
- (2021) Paul M Ridker et al. CIRCULATION RESEARCH
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Global epidemiology of dyslipidaemias
- (2021) Angela Pirillo et al. Nature Reviews Cardiology
- Metabolic-associated fatty liver disease and lipoprotein metabolism
- (2021) Joerg Heeren et al. Molecular Metabolism
- Nonalcoholic Fatty Liver Disease and Cardiac Remodeling Risk: Pathophysiological Mechanisms and Clinical Implications
- (2021) Jianghua Zhou et al. HEPATOLOGY
- Renin-Angiotensin System in Pathogenesis of Atherosclerosis and Treatment of CVD
- (2021) Anastasia V. Poznyak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Insulin resistance, cardiovascular stiffening and cardiovascular disease
- (2021) Michael A. Hill et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Fibrinogen and a Triad of Thrombosis, Inflammation, and the Renin-Angiotensin System in Premature Coronary Artery Disease in Women: A New Insight into Sex-Related Differences in the Pathogenesis of the Disease
- (2021) Karolina E. Kryczka et al. Biomolecules
- An update on factor XII-driven vascular inflammation
- (2021) Reiner K. Mailer et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
- (2021) Stanisław Surma et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Liver damage promotes pro‐inflammatory T‐cell responses against apolipoprotein B‐100
- (2021) Bastian F. J. Plochg et al. JOURNAL OF INTERNAL MEDICINE
- Linking liver metabolic and vascular disease via bile acid signaling
- (2021) Stefano Fiorucci et al. TRENDS IN MOLECULAR MEDICINE
- The presence of NAFLD influences the transition of metabolically healthy to metabolically unhealthy obesity and the ten-year cardiovascular disease risk: A population-based cohort study
- (2021) Matina Kouvari et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fibrin(ogen) in human disease: both friend and foe
- (2020) Rui Vilar et al. HAEMATOLOGICA
- Epidemiological feature of NAFLD from 1999 to 2018 in China
- (2020) Jianghua Zhou et al. HEPATOLOGY
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Regulation of apolipoprotein B by natural products and nutraceuticals: a comprehensive review
- (2020) Mohammad Bagherniya et al. CURRENT MEDICINAL CHEMISTRY
- Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
- (2020) Alan Chait et al. DIABETES
- Nonalcoholic Steatohepatitis
- (2020) Adam C. Sheka et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase
- (2020) Mei-Xin Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease
- (2020) Edward K. Duran et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
- (2020) Mengying Yang et al. Frontiers in Pharmacology
- Trimethylamine N-Oxide levels are associated with NASH in obese subjects with type 2 diabetes
- (2020) Paola León-Mimila et al. DIABETES & METABOLISM
- Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories
- (2020) Stefano Ciardullo et al. HYPERTENSION
- Metabolic drivers of non-alcoholic fatty liver disease
- (2020) Kendra K. Bence et al. Molecular Metabolism
- Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease
- (2020) Alessandro Ciavarella et al. THROMBOSIS RESEARCH
- Discovery of an orally active VHL-recruiting PROTAC that achieves robust HMGCR degradation and potent hypolipidemic activity in vivo
- (2020) Guoshun Luo et al. Acta Pharmaceutica Sinica B
- Nonalcoholic Fatty Liver Disease and the Heart
- (2019) Eric P. Stahl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Immunotherapy for cardiovascular disease
- (2019) Esther Lutgens et al. EUROPEAN HEART JOURNAL
- Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis
- (2019) Xiaoye Cheng et al. THROMBOSIS RESEARCH
- Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation
- (2019) Patricia Marchio et al. Oxidative Medicine and Cellular Longevity
- Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction
- (2019) Sifan Chen et al. Cell Metabolism
- Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
- (2019) Juliette Mouries et al. JOURNAL OF HEPATOLOGY
- Hepatocyte-Derived Extracellular Vesicles Promote Endothelial Inflammation and Atherogenesis via microRNA-1
- (2019) Fangjie Jiang et al. JOURNAL OF HEPATOLOGY
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity — A randomized trial
- (2018) Nathan C. Winn et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- Microbial modulation of cardiovascular disease
- (2018) J. Mark Brown et al. NATURE REVIEWS MICROBIOLOGY
- Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
- (2018) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue factor (:Factor VIIa) in the heart and vasculature: More than an envelope
- (2018) E. D'Alessandro et al. THROMBOSIS RESEARCH
- Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
- (2018) Jingjing Cai et al. Annual Review of Pathology-Mechanisms of Disease
- Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
- (2018) Luigi Ferrucci et al. Nature Reviews Cardiology
- Interactions between dyslipidemia and the immune system and their relevance as putative therapeutic targets in atherosclerosis
- (2018) Michael Lacy et al. PHARMACOLOGY & THERAPEUTICS
- Modulation of Insulin Resistance in NAFLD
- (2018) Reenam Khan et al. HEPATOLOGY
- Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol
- (2018) Shi-You Jiang et al. Nature Communications
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases
- (2017) Leon A Adams et al. GUT
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Interleukin-1 Beta as a Target for Atherosclerosis Therapy
- (2017) Peter Libby JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Regulation of hepatic glucose metabolism in health and disease
- (2017) Max C. Petersen et al. Nature Reviews Endocrinology
- Progression of carotid vascular damage and cardiovascular events in non-alcoholic fatty liver disease patients compared to the general population during 10 years of follow-up
- (2016) Anna Ludovica Fracanzani et al. ATHEROSCLEROSIS
- Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
- (2016) Weifei Zhu et al. CELL
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Selective Insulin Resistance and the Development of Cardiovascular Diseases in Diabetes: The 2015 Edwin Bierman Award Lecture
- (2016) George L. King et al. DIABETES
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease and Incident Cardiac Events
- (2016) Irfan Zeb et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease
- (2016) Yu Wu et al. LIVER INTERNATIONAL
- Association of blood pressure level with nonalcoholic fatty liver disease in nonhypertensive population
- (2016) Lin-Yan Qian et al. MEDICINE
- Non-alcoholic fatty liver disease and dyslipidemia: An update
- (2016) Niki Katsiki et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults
- (2016) Yu-ming Chen et al. Scientific Reports
- De novolipogenesis in the liver in health and disease: more than just a shunting yard for glucose
- (2015) Francis W. B. Sanders et al. BIOLOGICAL REVIEWS
- Severity of Nonalcoholic Fatty Liver Disease and Progression to Cirrhosis Are Associated With Atherogenic Lipoprotein Profile
- (2015) Mohammad S. Siddiqui et al. Clinical Gastroenterology and Hepatology
- High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial
- (2015) Sophie Cassidy et al. DIABETOLOGIA
- Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
- (2015) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
- (2015) Guanghong Jia et al. Nature Reviews Endocrinology
- Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target
- (2014) Enrica Golia et al. Current Atherosclerosis Reports
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The pathophysiology of hypertension in patients with obesity
- (2014) Vincent G. DeMarco et al. Nature Reviews Endocrinology
- Recent advances in pharmacotherapy for hypertriglyceridemia
- (2014) Amirhossein Sahebkar et al. PROGRESS IN LIPID RESEARCH
- Overview of Epidemiology and Contribution of Obesity to Cardiovascular Disease
- (2013) Marjorie Bastien et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Angiotensin Peptides and Nitric Oxide in Cardiovascular Disease
- (2012) Kaushik P. Patel et al. ANTIOXIDANTS & REDOX SIGNALING
- Glycation and Insulin Resistance
- (2012) Fei Song et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
- (2012) Chirag H. Mandavia et al. LIFE SCIENCES
- Over-nutrition and metabolic cardiomyopathy
- (2012) Chirag H. Mandavia et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Splice variants of tissue factor promote monocyte-endothelial interactions by triggering the expression of cell adhesion molecules via integrin-mediated signaling
- (2011) R. SRINIVASAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
- (2011) Zeneng Wang et al. NATURE
- Sympathetic Nervous System Modulation of Inflammation and Remodeling in the Hypertensive Heart
- (2010) Scott P. Levick et al. HYPERTENSION
- Targeting mitochondrial biogenesis for preventing and treating insulin resistance in diabetes and obesity: Hope from natural mitochondrial nutrients☆
- (2009) Jiankang Liu et al. ADVANCED DRUG DELIVERY REVIEWS
- Signaling mechanisms of angiotensin II in regulating vascular senescence
- (2009) Li-Juan Min et al. AGEING RESEARCH REVIEWS
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
- (2009) Luca Miele et al. HEPATOLOGY
- Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue
- (2009) Hiroshi Kudo et al. LIVER INTERNATIONAL
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More